Answers are grounded in this paper and cite their sources.
Authors explore pharmacological uses of antipsychotics, highlighting the need for strong evidence in unlicensed indications.
Antipsychotics might be thought of as pleuripotent broad-spectrum psychotropics, given the versatile pharmacological portfolio, with a multitude of uses on clinical grounds, albeit off-label. Herein, authors would touch briefly on the general pharmacology and therapeutic potential of antipsychotics. Nonetheless, It should be borne in mind, that the level of evidence supporting the use of antipsychotics in many of these unlicensed indications remain, at large, flimsy, and other agents with solid evidence-base should be explored first.
No takes yet. Share an insight, caveat, or question.
Naguy et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: